Article
The Regulatory Accountability Act of 2017 - Implications for FDA Regulation and Public Health
New England Journal of Medicine
Document Type
Article
Publication Date
2-1-2018
Disciplines
DOI
10.1056/NEJMp1711643
Citation Information
Jonathan J. Darrow, Erin C. Fuse Brown, & Aaron S. Kesselheim, The Regulatory Accountability Act of 2017 - Implications for FDA Regulation and Public Health, 378 N. Eng. J. Med. 412 (2018).
External Links
Westlaw